Alvarez-Llamas G - Search Results

1

Urine 2DE proteome analysis in healthy condition and kidney disease.

Martin-Lorenzo M, Gonzalez-Calero L, Zubiri I, Diaz-Payno PJ, Sanz-Maroto A, Posada-Ayala M, Ortiz A, Vivanco F, Alvarez-Llamas G. Martin-Lorenzo M, et al. Electrophoresis. 2014 Sep;35(18):2634-41. doi: 10.1002/elps.201300601. Epub 2014 Aug 14. Electrophoresis. 2014. PMID: 24913465

2

Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.

Alvarez-Llamas G, de la Cuesta F, Barderas ME, Darde V, Padial LR, Vivanco F. Alvarez-Llamas G, et al. Expert Rev Proteomics. 2008 Oct;5(5):679-91. doi: 10.1586/14789450.5.5.679. Expert Rev Proteomics. 2008. PMID: 18937558 Review.

3

Pharmacoproteomics in cardiac hypertrophy and atherosclerosis.

Lazaro A, Alvarez-Llamas G, Gallego-Delgado J, de la Cuesta F, Osende J, Barderas ME, Vivanco F. Lazaro A, et al. Cardiovasc Hematol Disord Drug Targets. 2009 Jun;9(2):141-8. doi: 10.2174/187152909788488672. Cardiovasc Hematol Disord Drug Targets. 2009. PMID: 19519373 Review.

4

Proteomic Biomarkers of Atherosclerosis.

Vivanco F, Padial LR, Darde VM, de la Cuesta F, Alvarez-Llamas G, Diaz-Prieto N, Barderas MG. Vivanco F, et al. Biomark Insights. 2008 Mar 12;3:101-113. doi: 10.4137/bmi.s488. Biomark Insights. 2008. PMID: 19578499 Free PMC article.

5

Tissue proteomics in atherosclerosis: elucidating the molecular mechanisms of cardiovascular diseases.

de la Cuesta F, Alvarez-Llamas G, Gil-Dones F, Martin-Rojas T, Zubiri I, Pastor C, Barderas MG, Vivanco F. de la Cuesta F, et al. Expert Rev Proteomics. 2009 Aug;6(4):395-409. doi: 10.1586/epr.09.60. Expert Rev Proteomics. 2009. PMID: 19681675 Review.

6

A novel methodology for the analysis of membrane and cytosolic sub-proteomes of erythrocytes by 2-DE.

Alvarez-Llamas G, de la Cuesta F, Barderas MG, Darde VM, Zubiri I, Caramelo C, Vivanco F. Alvarez-Llamas G, et al. Electrophoresis. 2009 Dec;30(23):4095-108. doi: 10.1002/elps.200900046. Electrophoresis. 2009. PMID: 19960473

7

Development of an optimal protocol for the proteomic analysis of stenotic and healthy aortic valves.

Gil-Dones F, Martín-Rojas T, López-Almodovar LF, Juárez-Tosina R, de la Cuesta F, Alvarez-Llamas G, Alonso-Orgaz S, Vivanco F, Rodríguez-Padial L, Barderas MG. Gil-Dones F, et al. Rev Esp Cardiol. 2010 Jan;63(1):46-53. doi: 10.1016/s1885-5857(10)70008-6. Rev Esp Cardiol. 2010. PMID: 20089225 Free article. English, Spanish.

8

Analysis of the plasma proteome associated with acute coronary syndrome: does a permanent protein signature exist in the plasma of ACS patients?

Dardé VM, de la Cuesta F, Dones FG, Alvarez-Llamas G, Barderas MG, Vivanco F. Dardé VM, et al. J Proteome Res. 2010 Sep 3;9(9):4420-32. doi: 10.1021/pr1002017. J Proteome Res. 2010. PMID: 20597552

9

Vascular proteomics.

Vivanco F, Mas S, Darde VM, De la Cuesta F, Alvarez-Llamas G, Barderas MG. Vivanco F, et al. Proteomics Clin Appl. 2007 Sep;1(9):1102-22. doi: 10.1002/prca.200700190. Proteomics Clin Appl. 2007. PMID: 21136761

10

An optimum method designed for 2-D DIGE analysis of human arterial intima and media layers isolated by laser microdissection.

de la Cuesta F, Alvarez-Llamas G, Maroto AS, Donado A, Juarez-Tosina R, Rodriguez-Padial L, Pinto AG, Barderas MG, Vivanco F. de la Cuesta F, et al. Proteomics Clin Appl. 2009 Oct;3(10):1174-84. doi: 10.1002/prca.200900053. Proteomics Clin Appl. 2009. PMID: 21136942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters